Back to Search

DAVID HECHT, MD

MD

Infectious Disease Physician

NPI: 1306823208Individual

Specialties, Licenses & Credentials

Infectious Disease PhysicianPrimary

Internal Medicine — Infectious Disease

Code: 207RI0200X

36077809(IL)

Research & Publications (20)

In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
PMID 17517836·Antimicrob Agents Chemother·2007
8-other
Characterization of BctA, a mating apparatus protein required for transfer of the Bacteroides fragilis conjugal element BTF-37.
PMID 17720457·Res Microbiol·2007
8-other
Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing.
PMID 16765857·Anaerobe·2006
6-review
Molecular characterization of imipenem-resistant, cfiA-positive Bacteroides fragilis isolates from the USA, Hungary and Kuwait.
PMID 15096551·J Med Microbiol·2004
8-other
Evolution of anaerobe susceptibility testing in the United States.
PMID 12173105·Clin Infect Dis·2002
8-other
Schizophrenia, the sense of 'self' and the right cerebral hemisphere.
PMID 19665853·Med Hypotheses·2010
8-other
Repetition priming for multisensory stimuli: task-irrelevant and task-relevant stimuli are associated if semantically related but with no advantage over uni-sensory stimuli.
PMID 19022232·Brain Res·2009
8-other
Sensory dominance in combinations of audio, visual and haptic stimuli.
PMID 18985327·Exp Brain Res·2009
8-other
Enhancement of response times to bi- and tri-modal sensory stimuli during active movements.
PMID 17992522·Exp Brain Res·2008
4-observational
Multisensory enhancement: gains in choice and in simple response times.
PMID 18478210·Exp Brain Res·2008
4-observational
Field dependency and the sense of object-presence in haptic virtual environments.
PMID 17474842·Cyberpsychol Behav·2007
8-other
Activities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates.
PMID 12604521·Antimicrob Agents Chemother·2003
8-other
Charge transport in interpenetrating networks of semiconducting and metallic carbon nanotubes.
PMID 19331424·Nano Lett·2009
8-other
A novel in silico approach to drug discovery via computational intelligence.
PMID 19348414·J Chem Inf Model·2009
8-other
The impact of evidence-based practice implementation and fidelity monitoring on staff turnover: evidence for a protective effect.
PMID 19309186·J Consult Clin Psychol·2009
8-other
Surface-modified nanotube anodes for high performance organic light-emitting diode.
PMID 19588907·ACS Nano·2009
8-other
Behavioral indications of object-presence in haptic virtual environments.
PMID 19132912·Cyberpsychol Behav·2009
8-other
On the relationship between GC content and the number of predicted microRNA binding sites by MicroInspector.
PMID 18407791·Comput Biol Chem·2008
8-other
Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.
PMID 18559647·Antimicrob Agents Chemother·2008
8-other
Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea.
PMID 18680416·Clin Infect Dis·2008
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2160 S 1ST AVE, (LUH-NORTH ENT., RM. 7604)
MAYWOOD, IL 60153

Location

Practice Location

2160 S 1ST AVE, MAYWOOD, IL
(708) 216-3232

Quick Facts

NPI
1306823208
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile